We see Tecentriq gaining momentum in lung cancer. by Baader Helvea

We see Tecentriq gaining momentum in lung cancer.

Baader Helvea

Image Embed Code

Categorized in : Company News

While the IB unit delivered a strong beat, other units, particularly Global Wealth Management (with a small, approximately 1 percent miss on both assets under management and gross margin) slightly disappointed.